4.7 Article

Minimal Elements Required for the Formation of Respiratory Syncytial Virus Cytoplasmic Inclusion Bodies In Vivo and In Vitro

期刊

MBIO
卷 11, 期 5, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.01202-20

关键词

RSV; inclusion bodies; liquid-liquid phase; nucleoprotein; phosphoprotein; protein-protein interactions

资金

  1. region Ile-de-France
  2. ATIP-Avenir program (INSERM)
  3. French Agence Nationale de la Recherche, specific program ANR PRC DecRisp [ANR-19-CE11-0017]
  4. Agence Nationale de la Recherche (ANR) [ANR-19-CE11-0017] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

Infection of host cells by the respiratory syncytial virus (RSV) is characterized by the formation of spherical cytoplasmic inclusion bodies (IBs). These structures, which concentrate all the proteins of the polymerase complex as well as some cellular proteins, were initially considered aggresomes formed by viral dead-end products. However, recent studies revealed that IBs are viral factories where viral RNA synthesis, i.e., replication and transcription, occurs. The analysis of IBs by electron microscopy revealed that they are membrane-less structures, and accumulated data on their structure, organization, and kinetics of formation revealed that IBs share the characteristics of cellular organelles, such as P-bodies or stress granules, suggesting that their morphogenesis depends on a liquid-liquid phase separation mechanism. It was previously shown that expression of the RSV nucleoprotein N and phosphoprotein P of the polymerase complex is sufficient to induce the formation of pseudo-IBs. Here, using a series of truncated P proteins, we identified the domains of P required for IB formation and show that the oligomeric state of N, provided it can interact with RNA, is critical for their morphogenesis. We also show that pseudo-IBs can form in vitro when recombinant N and P proteins are mixed. Finally, using fluorescence recovery after photobleaching approaches, we reveal that in cellula and in vitro IBs are liquid organelles. Our results strongly support the liquid-liquid phase separation nature of IBs and pave the way for further characterization of their dynamics. IMPORTANCE Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness in infants, elderly, and immunocompromised people. No vaccine or efficient antiviral treatment is available against this virus. The replication and transcription steps of the viral genome are appealing mechanisms to target for the development of new antiviral strategies. These activities take place within cytoplasmic inclusion bodies (IBs) that assemble during infection. Although expression of both the viral nucleoprotein (N) and phosphoprotein (P) allows induction of the formation of these IBs, the mechanism sustaining their assembly remains poorly characterized. Here, we identified key elements of N and P required for the scaffolding of IBs and managed for the first time to reconstitute RSV pseudo-IBs in vitro by coincubating recombinant N and P proteins. Our results provide strong evidence that the biogenesis of RSV IBs occurs through liquid-liquid phase transition mediated by N-P interactions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Virology

Tetramerization of Phosphoprotein Is Essential for Respiratory Syncytial Virus Budding while Its N-Terminal Region Mediates Direct Interactions with the Matrix Protein

Monika Bajorek, Marie Galloux, Charles-Adrien Richard, Or Szekely, Rina Rosenzweig, Christina Sizun, Jean-Francois Eleouet

Summary: This study investigates the interaction between the matrix (M) and phosphoprotein (P) during respiratory syncytial virus (RSV) assembly and budding, revealing a direct interaction between M and P and identifying novel interaction sites on P. The findings highlight the importance of the tetrameric structural organization of P and the oligomerization domain (OD) for virus-like filament formation and VLP release.

JOURNAL OF VIROLOGY (2021)

Article Virology

New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution

Maxence Fretaud, Delphyne Descamps, Daphne Laubreton, Marie-Anne Rameix-Welti, Jean-Francois Eleouet, Thibaut Larcher, Marie Galloux, Christelle Langevin

Summary: The combination of tissue clearing, 3D microscopy, and image processing has led to the development of a novel visualization tool for RSV infection in undissected mouse lungs, allowing for the identification of infected cell subtypes and cytoplasmic viral factories. This new method provides unprecedented insights into RSV pathophysiology and enhances 2D histology analyses.

VIRUSES-BASEL (2021)

Article Geriatrics & Gerontology

Molecular investigation of a RSV outbreak in a geriatric hospital

Yohan Hababou, Assia Taleb, Amelie Recoing, Frederique Moreau, Isabelle Simon, Florence Muller de Schongor, Elyanne Gault, Marie-Anne Rameix-Welti

Summary: Acquired infections in hospitalized elderly people are a growing concern, with virus outbreaks posing a common challenge for infection prevention teams in long-term care facilities. A study in a long-term care hospital in Paris revealed RSV RNA in respiratory samples from 19 patients, with genotyping identifying 12 nosocomial cases in a unique cluster with an average age of 89 for outbreak cases.

BMC GERIATRICS (2021)

Letter Critical Care Medicine

Monocyte distribution width as a biomarker of resistance to corticosteroids in patients with sepsis: the MOCORSEP observational study

Djillali Annane, Martin Rottman, Nicholas Heming, Veronique Godot, Jerome Fleuriet, Jean Sebastien Blanchet, Pierre Moine, Lamiae Grimaldi, Sylvie Chevret

INTENSIVE CARE MEDICINE (2021)

Article Multidisciplinary Sciences

A condensate-hardening drug blocks RSV replication in vivo

Jennifer Risso-Ballester, Marie Galloux, Jingjing Cao, Ronan Le Goffic, Fortune Hontonnou, Aude Jobart-Malfait, Aurore Desquesnes, Svenja M. Sake, Sibylle Haid, Miaomiao Du, Xiumei Zhang, Huanyun Zhang, Zhaoguo Wang, Vincent Rincheval, Youming Zhang, Thomas Pietschmann, Jean-Francois Eleouet, Marie-Anne Rameix-Welti, Ralf Altmeyer

Summary: The study demonstrates that cyclopamine and its analogue A3E inhibit RSV replication by disorganizing and hardening inclusion bodies. These small molecules act directly on the liquid properties of inclusion bodies, disrupting them within minutes. Cyclopamine and A3E also inhibit RSV in infected mice, showing in vivo activity as condensate-targeting drugs.

NATURE (2021)

Article Microbiology

Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection

Melanie Brugger, Thomas Demoulins, G. Tuba Barut, Beatrice Zumkehr, Blandina I. Oliveira Esteves, Kemal Mehinagic, Quentin Haas, Aline Schogler, Marie-Anne Rameix-Welti, Jean-Francois Eleouet, Ueli Moehrlen, Thomas M. Marti, Ralph A. Schmid, Artur Summerfield, Horst Posthaus, Nicolas Ruggli, Sean R. R. Hall, Marco P. Alves

Summary: The research highlights the critical role of lung-resident MSCs in virus-induced acute lung injury, showing their involvement in immune response, repair mechanisms, and expansion of the pulmonary MSC pool following infection. These findings contribute to a better understanding of host response and lung repair mechanisms, with potential therapeutic implications.

PLOS PATHOGENS (2021)

Article Immunology

Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Emilie Jacque, Claire Chottin, Daphne Laubreton, Michel Nogre, Cecile Ferret, Sandrine de Marcos, Linda Baptista, Carole Drajac, Philippe Mondon, Christophe De Romeuf, Marie-Anne Rameix-Welti, Jean-Francois Eleouet, Sami Chtourou, Sabine Riffault, Gerald Perret, Delphyne Descamps

Summary: The article introduces a new type of anti-respiratory syncytial virus (RSV) immunoglobulin, manufactured through an innovative bioprocess, with high purity and concentration, and strong neutralizing effects on the virus. Experimental results show that low doses of hyper-enriched anti-RSV IgG can be administered locally to ensure rapid and efficient inhibition of virus infection, which may have promising applications in preventing and treating other infectious diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Importance of RNA length for in vitro encapsidation by the nucleoprotein of human respiratory syncytial virus

Lorene Gonnin, Charles-Adrien Richard, Irina Gutsche, Didier Chevret, Joris Troussier, Jean-Jacques Vasseur, Francoise Debart, Jean-Francois Eleoue, Marie Galloux

Summary: Respiratory syncytial virus has a negative-sense single-stranded RNA genome encapsidated by the viral nucleoprotein N. The recruitment of L protein onto the nucleoprotein depends on the viral phosphoprotein P. The interaction between P and N complexed with RNA is responsible for the morphogenesis of viral factories.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Microbiology

Respiratory syncytial virus ribonucleoproteins hijack microtubule Rab11 dependent transport for intracellular trafficking

Gina Cosentino, Katherine Marougka, Aurore Desquesnes, Nicolas Welti, Delphine Sitterlin, Elyanne Gault, Marie-Anne Rameix-Welti

Summary: This study reveals that RSV RNPs move within cells by utilizing microtubules and the endosome recycling pathway, shedding light on the transportation mechanism of vRNPs.

PLOS PATHOGENS (2022)

Article Infectious Diseases

Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection

Matthieu Receveur, Michele Ottmann, Jean-Marc Reynes, Jean-Francois Eleouet, Marie Galloux, Aurore Receveur, Dominique Ploin, Sylvie Fiorini, Nathalie Rivat, Martine Valette, Bruno Lina, Jean-Sebastien Casalegno

Summary: This study investigated the association between maternal antibody titers against the RSV nucleoprotein (N protein) at birth and the risk of newborns developing very severe lower respiratory tract infection (VS-LRTI). The results showed that the antibody titers were significantly lower in newborns with risk factors for RSV severe LRTI, but there was no association between antibody titer and protection against VS-LRTI. Further studies are needed to determine if transfer of maternal antibodies against RSV N protein can provide early immune protection in infants.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Biochemistry & Molecular Biology

Investigation of the Fuzzy Complex between RSV Nucleoprotein and Phosphoprotein to Optimize an Inhibition Assay by Fluorescence Polarization

Silva Khodjoyan, Deborha Morissette, Fortune Hontonnou, Luis Checa Ruano, Charles-Adrien Richard, Olivier Sperandio, Jean-Francois Eleouet, Marie Galloux, Philippe Durand, Stephanie Deville-Foillard, Christina Sizun

Summary: The interaction between Respiratory Syncytial Virus phosphoprotein P and nucleoprotein N is crucial for the formation of the RSV polymerase. We investigated the binding affinities and dynamics of this interaction using nuclear magnetic resonance and fluorescence polarization. We optimized parameters for a robust RSV N-P inhibition assay and validated it with the M76 molecule for further chemical library screening.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Hardening of Respiratory Syncytial Virus Inclusion Bodies by Cyclopamine Proceeds through Perturbation of the Interactions of the M2-1 Protein with RNA and the P Protein

Cedric Diot, Charles-Adrien Richard, Jennifer Risso-Ballester, Davy Martin, Jenna Fix, Jean-Francois Eleouet, Christina Sizun, Marie-Anne Rameix-Welti, Marie Galloux

Summary: Respiratory syncytial virus (RSV) RNA synthesis occurs in membrane-less organelles called inclusion bodies (IBs), driven by liquid-liquid phase separation. Cyclopamine (CPM) inhibits RSV multiplication by disorganizing and hardening IBs. The activity of CPM depends on the viral transcription factor M2-1, and it affects the competition between P and RNA binding to M2-1. These findings suggest that stabilizing viral protein-protein interactions is a promising antiviral approach for RSV.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Virology

Characterization of the Interaction Domains between the Phosphoprotein and the Nucleoprotein of Human Metapneumovirus

Hortense Decool, Benjamin Bardiaux, Luis Checa Ruano, Olivier Sperandio, Jenna Fix, Irina Gutsche, Charles-Adrien Richard, Monika Bajorek, Jean-Francois Eleouet, Marie Galloux

Summary: Human metapneumovirus (HMPV) causes severe respiratory diseases, but the molecular mechanisms involved in viral replication are not fully understood. In this study, researchers investigated the interaction between two major viral proteins involved in HMPV RNA synthesis, and characterized their domains of interaction. They also identified a potential target on the surface of the N protein for the design of antiviral compounds.

JOURNAL OF VIROLOGY (2022)

暂无数据